Deranged platelet calcium homeostasis in diabetic patients with end- stage renal failure: A possible link to increased cardiovascular mortality?

Diabetes Care

Volumn 19, Issue 10, 1996, Pages 1062-1066

  Vicari, Aurelio M ^a   Melandri, Marco ^a   Taglietti, Maria V ^a   Galli, Laura ^a   Pellegatta, Fabio ^a   Ronchi, Paola ^a   Spotti, Donatella ^a   Folli, Franco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; FURA 2; THROMBIN;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY FAILURE; MALE; THROMBOCYTE; UREMIA;

EID: 10144222647     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.10.1062     Document Type: Article

References (52)

1. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328: 1676-1685, 1993
2. Vicari AM, Macagni A: Primary platelet activation in recent-onset type 1 diabetes mellitus. Scand J Clin Lab Invest 50: 429-443, 1990
3. Winocour PD: Platelet abnormalities in diabetes mellitus. Diabetes 41 (Suppl. 2):26-31, 1992
4. Hellem AJ: Adenosine disphosphate-induced platelet adhesiveness in diabetes mellitus with complications. Acta Med Scand 90:291-295, 1971
5. Colwell JA, Haluska PV, Sarji K: Altered platelet function in diabetes mellitus. Diabetes 25:826-831, 1976
6. Burrows AW, Chavin SI, Hockaday TDR: Plasma thromboglobulin concentrations in diabetes mellitus. Lancet i:235-237, 1979
7. Kinlough-Rathborne RL, Packham MA, Mustard JF: Vessel injury, platelet adherence, and platelet survival. Arteriosclerosis 3:529-546, 1983
8. Remuzzi G: Bleeding in renal failure. Lancet i:1205-1208, 1988
9. Remuzzi G, Cavenaghi AE, Mecca G, Donati MB, De Gaetano G: Prostacyclin-like activity and bleeding in renal failure. Lancet ii:1195-1197, 1977
10. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: implications for platelet dysfunction and dialysis hypotension. Kidney Int 44:445-450, 1993
11. Kazatchkine M, Sultan Y, Caen JP, Bariety J: Bleeding in renal failure: a possible cause. Br Med J 2:612-615, 1976
12. Evans EP, Branch RA, Bloom AL: A clinical and experimental study of platelet function in chronic renal failure. J Clin Pathol 25:745-753, 1987
13. Remuzzi G, Benigni P, Dodesini P, Schieppati A, Livio M, Day JS, Smith WL, Pinca E, Patrignani P, Patrono C: Reduced platelet thomboxane formation in uremia: evidence for a functional cyclooxygenase defect. J Clin Invest 71:762-768, 1983
14. Gordge MP, Faint RW, Rylance PB, Neild GH: Platelet function and the bleeding time in progressive renal failure. Thromb Haem 60:83-87, 1988
15. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM, Boneu B: Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 59:139-148, 1985
16. Massry SG, Goldstein DA: The search for uremic toxin(s) "X"."X"= PTH. Clin Nephrol 11:181-189, 1979
17. Castaldi PA, Rozenberg MC, Stewart JH: The bleeding disorder of uremia. A qualitative platelet defect. Lancet i:66-69, 1966
18. Retting B, Teuthsh SM: The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diab Nephrop 3:26-27, 1984
19. Joint Working Party on Diabetic Renal Failure: Renal failure in diabetes in the UK: deficient provision of care in 1985. Diabetic Med 5:79-84, 1988
20. Eggers PW: Effect of transplantation on the Medicare end-stage renal disease program. N Engl J Med 318:223-229, 1988
21. Rink TJ, Sage SO: Calcium signaling in human platelets. Annu Rev Physiol 52:431-449, 1990
22. ++ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
23. Pellegatta F, Folli F, Ronchi P, Caspani L, Galli L, Vicari AM: Deranged platelet calcium homeostasis in poorly controlled IDDM patients. Diabetes Care 16:178-183, 1993
24. Scharf O, Foder B: Regulation of cytosolic calcium in blood cells. Phys Rev 73:547-582, 1993
25. Manning DR, Brass LF: The role of GTP-binding proteins in platelet activation. Thromb Haem 66:393-399, 1991
26. Takai Y, Kishimoto A, Kikkawa U, Mori T, Nishizuka Y: Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun 91:1218-1224, 1979
27. Daniel JL, Molish JR, Holmsen H: Myosin phosphorylation in intact platelets. J Biol Chem 259:9826-9831, 1981
28. ++ requirement, pH dependence, and cellular localization. J Biol Chem 255:10227-10231, 1980
29. ++ thresholds and Ca-independent activation for shape change. FEBS Lett 148:21-26, 1982
30. ++ in amine storage granule secretion by human platelets. Thromb Res 20:437-446, 1980
31. ++ on the surface of platelets. J Clin Invest 73:626-632, 1984
32. Siess W: Molecular mechanisms of platelet activation. Phys Rev 69:58-178, 1989
33. + transport in diabetes mellitus. Diabetes 39:850-854, 1990
34. Bergh CH, Hjalmarson A, Holm G, Angwald E, Jacobsson B: Studies on calcium exchange in platelets in human diabetes. Eur J Clin Invest 18:92-97, 1988
35. Ishii H, Umeda F, Hashimoto T, Nawata H: Increased intracellular calcium mobilization in platelets from patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:332-336, 1991
36. Tschope D, Rosen P, Gries FA: Increase in the cytosolic concentration of calcium in platelets of diabetics type IL Thromb Res 62:421-428, 1991
37. Raine AEG, Mac Mahon SM, Selwood NH, Wing AJ, Brunner FP: Mortality from myocardial infarction in patients on renal replacement therapy in the UK (Abstract). Nephrol Dial Transpl 6:902, 1991
38. Packham MA, Mustard JF: Platelet aggregation: relevance to thrombotic tendencies. Adv Exp Med Biol 102:51-72, 1978
39. Sobel M, Salzman EW, Davies GC, Handin Rl, Sweeney J, Ploetz J, Kurland G: Circulating platelet products in unstable angina pectoris. Circulation 63:300-306, 1981
40. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA: Platelet activation in unstable coro-nary disease. N Engl J Med 315:983-989, 1986
41. Ahn YS, Jy W, Harrington WJ, Shanbaky N, Fernandez LF, Haynes DH: Increased platelet calcium in thrombosis and related disorders and ils correction with nifedipine. Thromb Res 45:135-143, 1987
42. Joseph R, Welch KMA, Grunfeld S, Oster SB, D'Andrea G: Baseline and activated platelet cytoplasmic calcium in acute ischemic stroke. Effect of aspirin. Stroke 19:1236-1238, 1988
43. Vicari AM, Monzani ML, Pellegatta F, Ronchi P, Galli L, Folli F: Platelet calcium homeostasis is abnormal in patients with severe arteriosclerosis. Arterioscler Thromb 14:1420-1424, 1994
44. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2040, 1979
45. Whitley KY, Shapiro FL: Haemodialysis for end-stage diabetic nephropathy. In Diabetic Renal-Retinal Syndrome. Vol 3: Therapy. Friedman EA, L'Esperance FA Jr, Eds. New York, Grune and Stratton. 1986, p. 349-362
46. Jacobs C, Brunner FP, Brynger H, Shallah S, Kramer P, Selwood NH, Wing AJ: The first five thousand diabetics treated by dialysis and transplantation in Europe. Diabet Nephrop 2:12-16, 1983
47. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697-701, 1974
48. Krowlewski AS, Canessa M, Warram JH, Loffel LM, Christlieb AR, Knowler WC, Pend LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 318:140-145, 1988
49. Viberti G, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet i:1430-1432, 1982
50. Geiger J, Nolte C, Butt E, Sage O, Walter U: Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci USA 89:1031-1035, 1992
51. Gopalakrishna R, Chen ZH, Gundimeda U: Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 268:27180-27185, 1993
52. Radomski MW, Palmer RMJ, Moncada S: An L-arginine:nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 87:5193-5197, 1990